Tiny RNA clues may reveal why prostate cancer fights back
NCT ID NCT04662996
First seen Feb 15, 2026 · Last updated Apr 24, 2026 · Updated 9 times
Summary
This study looked at 33 men with advanced prostate cancer that no longer responded to hormone therapy. Researchers wanted to see if tiny molecules called microRNAs could predict which treatments—chemotherapy or newer hormone drugs—would stop working. The goal was to find biological clues to help doctors choose the right treatment from the start.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospital of Tours
Tours, 37044, France
Conditions
Explore the condition pages connected to this study.